Click HERE to download the PDF version
Xellia Pharmaceuticals is a world leader in the development, manufacture and supply of fermented anti-infectives sold as active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) to the global pharmaceutical market. The company’s product range covers anti-infectives, treating certain serious and life-threatening bacterial and fungal infections; Xellia being the world leading supplier of vancomycin and colistimethate sodium (CMS).
We as a company are conscious of the role we play in ensuring responsible manufacturing, and stable and reliable supply of our products.
As we work towards the development of both new and improved drugs to help tackle the global crisis of AMR, we have advanced our focus on improving the efficacy and safety profile of anti-infectives as well as towards reducing the side effec ... ...